Login / Signup

Anti-RANKL Antibody For Active Charcot Foot Neuro-Osteoarthropathy in Patients with Diabetes and Chronic Kidney Disease.

Pankaj MalhotraRaveena SinghJayaditya GhoshRajat Gupta
Published in: Foot & ankle international (2024)
Anti-RANKL antibody added to SoC (TCC) induces remission of active foot CNO in greater proportions of patients with diabetes and CKD.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • nuclear factor
  • bone loss
  • disease activity
  • rheumatoid arthritis
  • immune response
  • inflammatory response
  • systemic lupus erythematosus
  • ulcerative colitis